7113-02-2

Basic information

• Product Name: 2-PHENYLTHIAZOLE-4-CARBOXYLIC ACID METHYL ESTER
• Synonyms: RARECHEM AL BF 1318;METHYL 2-PHENYLTHIAZOLE-4-CARBOXYLATE;2-PHENYLTHIAZOLE-4-CARBOXYLIC ACID METHYL ESTER;2-Phenyl-4-thiazolecarboxylic acid methyl ester;Methyl 2-phenyl-1,3-thiazole-4-carboxylate;4-Thiazolecarboxylic acid, 2-phenyl-, Methyl ester
• CAS NO: 7113-02-2
• Molecular Formula: C₁₁H₉NO₂S
• Molecular Weight: 219.26
• Mol File: 7113-02-2.mol
• Article Data: 16

Chemical Properties

• Melting Point: 77-78℃
• Boiling Point: 353℃
• Flash Point: 167℃
• Appearance: /
• Density: 1.250
• CAS DataBase Reference: 2-PHENYLTHIAZOLE-4-CARBOXYLIC ACID METHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 2-PHENYLTHIAZOLE-4-CARBOXYLIC ACID METHYL ESTER(7113-02-2)
• EPA Substance Registry System: 2-PHENYLTHIAZOLE-4-CARBOXYLIC ACID METHYL ESTER(7113-02-2)

Safety Data

• Hazardous Substances Data: 7113-02-2(Hazardous Substances Data)

Usage

General Description

2-Phenylthiazole-4-carboxylic acid methyl ester is an organic compound with the molecular formula C11H9NO2S. It is a derivative of thiazole, a five-membered aromatic heterocyclic compound containing a sulfur atom and a nitrogen atom. This chemical compound is commonly used in the synthesis of pharmaceuticals and agrochemicals due to its versatile reactivity and biological activity. It is also used as a building block for the preparation of various chemical compounds and intermediates. Its methyl ester functional group makes it suitable for various chemical reactions and transformations, making it a valuable compound in organic synthesis.

Upstream product

• 186581-53-3 diazomethane 
• 7113-10-2 2-phenyl-1,3-thiazole-4-carboxylic acid 
• 2227-79-4 benzenecarbothioamide 
• 198991-76-3 methyl (4R)-2-phenylthiazolidine-4-carboxylate 
• 5673-91-6 dimethyl 3,3'-disulfanediyl(2R,2'R)-bis(2-benzamidopropanoate) 
• 7425-63-0 methyl 3-bromo-2-oxopropanoate 
• 70-23-5 ethyl Bromopyruvate 
• 932-90-1 Benzaldoxime 
• 100-47-0 benzonitrile 
• 100-52-7 benzaldehyde 
• 3113-46-0 2-phenyl-4,5-dihydro-thiazole-4-carboxylic acid methyl ester 
• 62096-93-9 2-phenyl-4,5-dihydrothiazole-4-carboxylic acid 
• 59418-09-6 4-thiazolecarboxylate methyl ester 
• 108-86-1 bromobenzene 

Downstream Products

• 79247-92-0 methyl 4-phenylthiazole-2-carboxylate 
• 68438-26-6 methyl 3-phenyl-1,2-thiazole-5-carboxylate 
• 1370731-63-7 methyl 2-phenyl-5-(3,4-dimethylphenyl)thiazole-4-carboxylate 
• 1340599-49-6 methyl 5-(2,5-dimethylphenyl)-2-phenylthiazole-4-carboxylate 
• 1370731-77-3 C₁₇H₈⁽²⁾H₅NO₂S 
• 1370731-74-0 methyl 2-phenyl-5-(3-nitrophenyl)thiazole-4-carboxylate 
• 1370731-70-6 methyl 2-phenyl-5-(3,5-dimethylphenyl)thiazole-4-carboxylate 
• 1370731-65-9 methyl 2-phenyl-5-(3,4-dichlorophenyl)thiazole-4-carboxylate 
• 1370731-59-1 methyl 2-phenyl-5-(4-methylphenyl)thiazole-4-carboxylate 
• 1370731-60-4 methyl 2-phenyl-5-(3-methylphenyl)thiazole-4-carboxylate 
• 1315510-22-5 dimethyl 2,2'-diphenyl-bis-5,5'-thiazole-4,4'-dicarboxylate 
• 1476848-13-1 1-(6-fluoro-4-((2-phenylthiazol-4-yl)methoxy)benzofuran-2-yl)ethanone 
• 1476848-14-2 2-bromo-1-(6-fluoro-4-((2-phenylthiazol-4-yl)methoxy)benzofuran-2-yl)ethanone 
• 1476848-16-4 6-(6-Chloro-4-((2-phenylthiazol-4-yl)methoxy)benzofuran-2-yl)-2-methoxyimidazo[2,1-b][1,3,4]thiadiazole 

Relevant articles and documents

Purple acid phosphatase inhibitors as leads for osteoporosis chemotherapeutics

Purple acid phosphatases (PAPs) are metalloenzymes that catalyse the hydrolysis of phosphate esters under acidic conditions. Their active site contains a Fe(III)Fe(II) metal centre in mammals and a Fe(III)Zn(II) or Fe(III)Mn(II) metal centre in plants. In humans, elevated PAP levels in serum strongly correlate with the progression of osteoporosis and metabolic bone malignancies, which make PAP a target suitable for the development of chemotherapeutics to combat bone ailments. Due to difficulties in obtaining the human enzyme, the corresponding enzymes from red kidney bean and pig have been used previously to develop specific PAP inhibitors. Here, existing lead compounds were further elaborated to create a series of inhibitors with Ki values as low as ～30 μM. The inhibition constants of these compounds were of comparable magnitude for pig and red kidney bean PAPs, indicating that relevant binding interactions are conserved. The crystal structure of red kidney bean PAP in complex with the most potent inhibitor in this series, compound 4f, was solved to 2.40 ? resolution. This inhibitor coordinates directly to the binuclear metal centre in the active site as expected based on its competitive mode of inhibition. Docking simulations predict that this compound binds to human PAP in a similar mode. This study presents the first example of a PAP structure in complex with an inhibitor that is of relevance to the development of anti-osteoporotic chemotherapeutics.

Concise synthesis of 2,4-disubstituted thiazoles from β-azido disulfides and carboxylic acids or anhydrides: Asymmetric synthesis of cystothiazole C

A novel and efficient method for the one-pot synthesis of 2,4-disubstituted thiazoles from carboxylic acids or anhydrides is presented. Based on this new method, the total synthesis of the bis-2,4-disubstituted bis(thiazoles) natural product cystothiazole C is also presented. This journal is

PAR4 AGONIST PEPTIDES

The present invention provides PAR4 agonist peptides. These peptides are useful for developing robust PAR4 receptor assays.